Assuming the mean analyst top line growth estimates and even higher CapEx estimates this company still trades at a tremendous discount at its current price.
Assuming an 2013 exit EBITDA multiple of 3.5 and sensitizing relative to WACCs between 9 and 13%, this company shoudl still be trading between $11.50-$11.75.
Similarly, using a very very conservative perpetuity growth rate of 2.5% and a WACC of 10.5% the target share price 8.62, implying over a 30% premium to what the stock is currently at.
Besides the technical analysis the company is the leader in its market and looking at its closest comp, it trades at a significant P/E and revenue multiple discount. I've never seen a company with such growth potential that has been so mistreated by the market. I think this is a very strong BUY for any investor.